EPO906 in Carcinoid and Other Neuroendocrine Tumors

Summary

This study will examine whether the new investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the growth of cells that cause metastatic carcinoid and other neuroendocrine tumors.

Timeline

Start

2002-07

Primary completion

2007-04

Completion

2007-04

Drugs

Indications